Adverse drug event trigger tool: a practical methodology for measuring medication related harm

被引:291
作者
Rozich, JD [1 ]
Haraden, CR
Resar, RK
机构
[1] Mayo Htlh Syst, Eau Claire, WI 54703 USA
[2] Inst Healthcare Improvement, Boston, MA USA
来源
QUALITY & SAFETY IN HEALTH CARE | 2003年 / 12卷 / 03期
关键词
D O I
10.1136/qhc.12.3.194
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Adverse drug events continue to be the single most frequent source of healthcare mishaps, continually placing patients at risk of injury. This is not unexpected, given that drug treatment is the most common medical intervention and medication use is a highly complex, multidisciplinary, and largely manual process. Assessing the actual safety of drug use has been historically difficult, mainly because traditional methods such as chart audits and voluntary reporting of data have been shown to be expensive, insensitive, and largely ineffective for detecting mistakes in drug administration and drug related adverse clinical events (ADEs). Computerized methods for detecting ADEs, employing sentinel words or "triggers" in a patient's medical record, are effective but expensive and require customized software linkage to pharmacy databases. This paper describes the use of the "trigger tool", a relatively low cost and "low tech" modification of the automated technique. The adapted technique appears to increase the rate of ADE detection approximately 50-fold over traditional reporting methodologies.
引用
收藏
页码:194 / 200
页数:7
相关论文
共 18 条
[1]  
[Anonymous], HOSP PHARM
[2]  
[Anonymous], 1992, Hospital pharmacy
[3]   RELATIONSHIP BETWEEN MEDICATION ERRORS AND ADVERSE DRUG EVENTS [J].
BATES, DW ;
BOYLE, DL ;
VLIET, MVV ;
SCHNEIDER, J ;
LEAPE, L .
JOURNAL OF GENERAL INTERNAL MEDICINE, 1995, 10 (04) :199-205
[4]   INCIDENCE OF ADVERSE DRUG EVENTS AND POTENTIAL ADVERSE DRUG EVENTS - IMPLICATIONS FOR PREVENTION [J].
BATES, DW ;
CULLEN, DJ ;
LAIRD, N ;
PETERSEN, LA ;
SMALL, SD ;
SERVI, D ;
LAFFEL, G ;
SWEITZER, BJ ;
SHEA, BF ;
HALLISEY, R ;
VANDERVLIET, M ;
NEMESKAL, R ;
LEAPE, LL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (01) :29-34
[5]  
Classen D C, 1992, Hosp Pharm, V27, P776
[6]   COMPUTERIZED SURVEILLANCE OF ADVERSE DRUG EVENTS IN HOSPITAL PATIENTS [J].
CLASSEN, DC ;
PESTOTNIK, SL ;
EVANS, RS ;
BURKE, JP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (20) :2847-2851
[7]   Adverse drug events in hospitalized patients - Excess length of stay, extra costs, and attributable mortality [J].
Classen, DC ;
Pestotnik, SL ;
Evans, RS ;
Lloyd, JF ;
Burke, JP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (04) :301-306
[8]  
CLASSEN DC, 1999, P ENH PAT SAF RED ER
[9]  
CLASSEN DC, 1993, P ANN S COMP APPL ME, P161
[10]   Drug-related deaths in a department of internal medicine [J].
Ebbesen, J ;
Buajordet, I ;
Erikssen, J ;
Brors, O ;
Hilberg, T ;
Svaar, H ;
Sandvik, L .
ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (19) :2317-2323